|
Delayed
Sao Paulo
15:29:53 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 85.86 BRL | -0.42% |
|
+3.90% | +9.74% |
| 09-28 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| 09-23 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
Stock exchange
Sao Paulo
VRTX34 85.86 R$
-0.42%
52.46K
R$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| VRTX | 525.46USD | -0.24% | 46.72M $ | ||
CBOE
| VRTX | 525.95USD | -0.49% | 3.37M $ | |
|
Tradegate
| VX1 | 462.55EUR | -0.45% | 80.02K € | |
|
Boerse Muenchen
| VX1 | 462.90EUR | -0.56% | 43.98K € | |
|
Mexican S.E.
| VRTX * | 9,242.00MXN | +3.44% | 656K $ | |
|
Börse Stuttgart
| VX1 | 461.60EUR | -0.61% | 2.31K € | |
|
London S.E.
| 0QZU | 503.38USD | -1.96% | 503.38 $ | |
|
Deutsche Boerse AG
| VX1 | 462.80EUR | +0.19% | 0 € | |
|
Wiener Boerse
| VRTX | 462.25EUR | -0.45% | 0 € | |
|
Xetra
| VX1 | 463.55EUR | +0.44% | 0 € | |
|
Borsa Italiana
| 1VRTX | 461.90EUR | -0.54% | 0 € | |
|
CBOE
| 0QZU | 322.40EUR | 0.00% | 0 € | |
|
CBOE
| 451.00EUR | 0.00% | 0 € | ||
| VRTX34 | 85.86BRL | -0.42% | 52.46K R$ | ||
| VRTX | 8,410.00ARS | -0.41% | 10.79M $ | ||
|
Buenos Aires S.E.
| VRTXD | 5.500USD | -0.18% | 1.36K $ |
Quotes 5-day view: Vertex Pharmaceuticals Incorporated
Delayed Quote Sao Paulo
| 2026-09-22 | 2026-09-23 | 2026-09-24 | 2026-09-28 | 2026-09-29 | |
|---|---|---|---|---|---|
| Last | R$82.64 | R$82.96 | R$85.02 | R$86.22 | R$85.86 |
| Volume | 4 | 33 | 169 | 6 | 611 |
| Change | +1.37% | +0.39% | +2.48% | +1.41% | -0.42% |
| Opening | R$82.75 | R$82.56 | R$81.30 | R$86.08 | R$85.77 |
| High | R$82.80 | R$82.96 | R$85.38 | R$86.22 | R$85.86 |
| Low | R$82.64 | R$82.08 | R$81.30 | R$86.08 | R$85.77 |
Performance
| 1 day | -0.42% | ||
| 1 week | +3.90% | ||
| Current month | -2.35% | ||
| 1 month | -2.75% | ||
| 3 months | +9.99% | ||
| 6 months | +20.38% | ||
| Current year | +9.74% | ||
| 1 year | +29.88% | ||
| 3 years | +57.05% | ||
| 5 years | +176.13% |
Volumes
marketsDaily volume
611
Estimated daily volume
3,273
Avg. Volume 20 sessions
347
Daily volume ratio
9.43
Avg. Volume 20 sessions BRL
29,793.42
Avg. Volume 20 sessions USD
5,759.31
Record volume 1
244,608
Record volume 2
224,864
Record volume 3
157,616
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (BRL)
133,505,472,498
Market Cap (USD)
133,505,472,498
Net sales (USD)
12,001,300,000
Number of employees
6,400
Sales / Employee (USD)
1,875,203
Free-Float
99.79%
Free-Float capitalization (BRL)
25,443,191,029
Free-Float capitalization (USD)
133,223,092,545
Average Daily Capital Traded
-.--%
Indicators
Moving average 5 days
85.02
Moving average 20 days
85.05
Moving average 50 days
83.05
Moving average 100 days
78.55
Price spread / (MMA5)
-0.98%
Price spread / (MMA20)
-0.95%
Price spread / (MMA50)
-3.27%
Price spread / (MMA100)
-8.51%
STIM
RSI 9 days
57.65
RSI 14 days
55.84
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.42% | +3.90% | +29.88% | +57.05% | 134B | |
| -0.04% | +2.50% | +54.62% | +119.17% | 1,056B | |
| -0.04% | -0.70% | +44.15% | +72.27% | 645B | |
| +0.06% | -0.52% | +13.89% | +77.87% | 465B | |
| -1.28% | -0.28% | +75.94% | +44.00% | 368B | |
| -0.09% | -4.02% | +34.13% | +40.54% | 335B | |
| -0.21% | +2.48% | +20.38% | +29.08% | 275B | |
| -0.97% | -1.14% | +9.89% | +12.22% | 255B | |
| -0.38% | +4.09% | +49.79% | +58.72% | 229B | |
| -0.91% | -0.84% | +35.22% | +102.56% | 188B | |
| Average | -0.41% | +0.12% | +36.79% | +61.35% | 394.93B | |
| Weighted average by Cap. | -0.25% | +0.30% | +41.05% | +73.40% |
Historical Quotes: Vertex Pharmaceuticals Incorporated
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 81.3 |  | 86.22 |
| 1 month | 80.64 | | 88.92 |
| Current year | 65.18 | | 89.01 |
| 1 year | 65.18 | | 89.01 |
| 3 years | 52.29 | | 93.56 |
| 5 years | 30.22 | | 93.56 |
| 10 years | 20.29 | | 93.56 |
Monthly variations
Annual variations
| 2026 | +9.74% | ||
| 2025 | +1.37% | ||
| 2024 | +24.52% | ||
| 2023 | +29.72% | ||
| 2022 | +23.65% | ||
| 2021 | +1.10% | ||
| 2020 | +40.02% | ||
| 2019 | +28.19% |
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
- Quotes Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
